Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
- PMID: 12324669
- PMCID: PMC1746193
- DOI: 10.1136/thorax.57.10.847
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
Erratum in
- Thorax. 2008 Aug;63(8):753
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is characterised by both an accelerated decline in lung function and periods of acute deterioration in symptoms termed exacerbations. The aim of this study was to investigate whether these are related.
Methods: Over 4 years, peak expiratory flow (PEF) and symptoms were measured at home daily by 109 patients with COPD (81 men; median (IQR) age 68.1 (63-74) years; arterial oxygen tension (PaO(2)) 9.00 (8.3-9.5) kPa, forced expiratory volume in 1 second (FEV(1)) 1.00 (0.7-1.3) l, forced vital capacity (FVC) 2.51 (1.9-3.0) l); of these, 32 (29 men) recorded daily FEV(1). Exacerbations were identified from symptoms and the effect of frequent or infrequent exacerbations (> or < 2.92 per year) on lung function decline was examined using cross sectional, random effects models.
Results: The 109 patients experienced 757 exacerbations. Patients with frequent exacerbations had a significantly faster decline in FEV(1) and peak expiratory flow (PEF) of -40.1 ml/year (n=16) and -2.9 l/min/year (n=46) than infrequent exacerbators in whom FEV(1) changed by -32.1 ml/year (n=16) and PEF by -0.7 l/min/year (n=63). Frequent exacerbators also had a greater decline in FEV(1) if allowance was made for smoking status. Patients with frequent exacerbations were more often admitted to hospital with longer length of stay. Frequent exacerbations were a consistent feature within a patient, with their number positively correlated (between years 1 and 2, 2 and 3, 3 and 4).
Conclusions: These results suggest that the frequency of exacerbations contributes to long term decline in lung function of patients with moderate to severe COPD.
Similar articles
-
Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25792820 Free PMC article.
-
Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.Respir Med. 2007 Jun;101(6):1305-12. doi: 10.1016/j.rmed.2006.10.012. Epub 2006 Nov 16. Respir Med. 2007. PMID: 17112715
-
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22. doi: 10.1164/ajrccm.157.5.9709032. Am J Respir Crit Care Med. 1998. PMID: 9603117
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
Relation of chronic obstructive pulmonary disease exacerbations to FEV(1)--an intricate tango.Respiration. 2009;77(2):229-35. doi: 10.1159/000162877. Epub 2008 Oct 7. Respiration. 2009. PMID: 18840996 Review.
Cited by
-
Correlation of a decline in aerobic capacity with development of emphysema in patients with chronic obstructive pulmonary disease: a prospective observational study.PLoS One. 2015 Apr 24;10(4):e0125053. doi: 10.1371/journal.pone.0125053. eCollection 2015. PLoS One. 2015. PMID: 25909949 Free PMC article.
-
Comparative study on health care utilization and hospital outcomes of severe acute exacerbation of chronic obstructive pulmonary disease managed by pulmonologists vs internists.Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:759-66. doi: 10.2147/COPD.S81267. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25926727 Free PMC article.
-
Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review.Ther Clin Risk Manag. 2015 Mar 25;11:481-7. doi: 10.2147/TCRM.S67491. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 25848294 Free PMC article. Review.
-
Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations.BMJ Open Respir Res. 2014 Dec 30;1(1):e000052. doi: 10.1136/bmjresp-2014-000052. eCollection 2014. BMJ Open Respir Res. 2014. PMID: 25562034 Free PMC article.
-
Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.Int J Chron Obstruct Pulmon Dis. 2012;7:789-96. doi: 10.2147/COPD.S31797. Epub 2012 Nov 27. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 23226015 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical